4548.T | Seikagaku Corporation Annual & Quarterly Balance

Annual Balance Sheets

(In JPY)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	83.59 Billion	75.62 Billion	75.24 Billion	69.91 Billion	68.5 Billion	80.23 Billion
Total Current Assets	41.54 Billion	46.71 Billion	48.62 Billion	43.55 Billion	40.44 Billion	34.39 Billion
Cash And Short Term Investments	21.79 Billion	28.77 Billion	32.17 Billion	26.08 Billion	20.88 Billion	16.7 Billion
Cash and Cash Equivalents	18.7 Billion	23.45 Billion	21.51 Billion	15.19 Billion	13.1 Billion	8.98 Billion
Short Term Investments	3.09 Billion	5.32 Billion	10.65 Billion	10.89 Billion	7.78 Billion	7.71 Billion
Net Receivables	8.21 Billion	6.4 Billion	6.03 Billion	7.08 Billion	6.16 Billion	8.3 Billion
Inventory	9.34 Billion	9.47 Billion	8.58 Billion	8.39 Billion	7.97 Billion	7.55 Billion
Other Current Assets	2.19 Billion	2.05 Billion	1.83 Billion	1.99 Billion	5.42 Billion	1.82 Billion
Total Non-Current Assets	42.04 Billion	28.91 Billion	26.61 Billion	26.35 Billion	28.05 Billion	45.84 Billion
Net PPE	15.21 Billion	11.32 Billion	10.02 Billion	8.3 Billion	7.66 Billion	19.65 Billion
Good Will And Intangible Assets	3.2 Billion	3.23 Billion	2.92 Billion	2.35 Billion	1.57 Billion	577 Million
Good Will	2.1 Billion	2.09 Billion	2.09 Billion	1.53 Billion	1.11 Billion	-
Intangible Assets	1.09 Billion	1.13 Billion	833 Million	818 Million	467 Million	577 Million
Long-Term Investments	18.79 Billion	14.35 Billion	13.6 Billion	15.7 Billion	18.81 Billion	25.61 Billion
Tax Assets	1.79 Billion	-273 Million	69 Million	-851 Million	-1.34 Billion	-1.37 Billion
Other Non Current Assets	3.04 Billion	273 Million	-1 Million	850 Million	1.34 Billion	1.37 Billion
Other Assets	-	1 Million	3 Million	3 Million	2 Million	2 Million
Total Liabilities	11.3 Billion	8.4 Billion	8.9 Billion	6.31 Billion	8.73 Billion	7.2 Billion
Total Current Liabilities	7.19 Billion	6.69 Billion	7.53 Billion	5.6 Billion	6.7 Billion	5.35 Billion
Account Payables	1.65 Billion	879 Million	680 Million	670 Million	613 Million	721 Million
Tax Payables	113 Million	36 Million	308 Million	7 Million	426 Million	42 Million
Short Term Debt	335 Million	337 Million	335 Million	414 Million	415 Million	333 Million
Deferred Revenue	520 Million	4.08 Billion	4.52 Billion	3.24 Billion	5.07 Billion	3.79 Billion
Other Current Liabilities	4.69 Billion	1.39 Billion	1.99 Billion	1.28 Billion	608 Million	505 Million
Total Non Current Liabilities	4.11 Billion	1.71 Billion	1.37 Billion	703 Million	2.02 Billion	1.84 Billion
Long-Term Debt	61 Million	52 Million	58 Million	57 Million	69 Million	49 Million
Deferred Revenue Non Current	-	36 Million	36 Million	40 Million	86 Million	39 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	143 Million	109 Million	111 Million	259 Million	427 Million	592 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	72.28 Billion	67.21 Billion	66.33 Billion	63.6 Billion	59.76 Billion	73.03 Billion
Stock Holders Equity	72.28 Billion	67.21 Billion	66.33 Billion	63.6 Billion	59.76 Billion	73.03 Billion
Common Stock	3.84 Billion	3.84 Billion	3.84 Billion	3.84 Billion	3.84 Billion	3.84 Billion
Retained Earnings	54.73 Billion	53.97 Billion	53.3 Billion	51.21 Billion	48.25 Billion	60.56 Billion
Accumulated other comprehensive income	10.66 Billion	6.37 Billion	4.69 Billion	3.85 Billion	2.99 Billion	3.97 Billion
Common Stock Equity	72.28 Billion	67.21 Billion	66.33 Billion	63.6 Billion	59.76 Billion	73.03 Billion
Capital Lease Obligation	61 Million	89 Million	93 Million	91 Million	108 Million	82 Million
Total Investments	21.88 Billion	13.23 Billion	12.73 Billion	14.37 Billion	17.47 Billion	24.11 Billion
Total Debt	396 Million	389 Million	393 Million	471 Million	484 Million	382 Million
Net Debt	-18.3 Billion	-23.06 Billion	-21.12 Billion	-14.72 Billion	-12.61 Billion	-8.6 Billion

Breakdown	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2	2023 Q1
Total Assets	83.41 Billion	83.59 Billion	83.59 Billion	79.88 Billion	79.62 Billion	77.06 Billion
Total Current Assets	41.47 Billion	41.54 Billion	41.54 Billion	42.76 Billion	43.83 Billion	45.64 Billion
Cash And Short Term Investments	21.26 Billion	21.79 Billion	21.79 Billion	22.11 Billion	23.38 Billion	25.7 Billion
Cash and Cash Equivalents	16.84 Billion	18.7 Billion	18.7 Billion	16.53 Billion	18.04 Billion	20.26 Billion
Short Term Investments	4.41 Billion	3.09 Billion	3.09 Billion	5.57 Billion	5.34 Billion	5.44 Billion
Net Receivables	7.3 Billion	8.21 Billion	8.21 Billion	8.03 Billion	8.56 Billion	8.6 Billion
Inventory	9.79 Billion	9.34 Billion	9.34 Billion	10.46 Billion	9.92 Billion	9.3 Billion
Other Current Assets	3.1 Billion	2.19 Billion	2.19 Billion	2.15 Billion	1.96 Billion	2.03 Billion
Total Non-Current Assets	41.94 Billion	42.04 Billion	42.04 Billion	37.12 Billion	35.78 Billion	31.42 Billion
Net PPE	15.99 Billion	15.21 Billion	15.21 Billion	14.02 Billion	13.12 Billion	11.87 Billion
Good Will And Intangible Assets	3.33 Billion	3.2 Billion	3.2 Billion	3.4 Billion	3.41 Billion	3.16 Billion
Good Will	2.14 Billion	2.1 Billion	2.1 Billion	2.22 Billion	2.24 Billion	2.07 Billion
Intangible Assets	1.19 Billion	1.09 Billion	1.09 Billion	1.17 Billion	1.16 Billion	1.09 Billion
Long-Term Investments	22.61 Billion	18.79 Billion	18.79 Billion	17.52 Billion	11.74 Billion	16.38 Billion
Tax Assets	1.19 Billion	1.79 Billion	1.79 Billion	1 Million	6.23 Billion	-270 Million
Other Non Current Assets	-1.19 Billion	3.04 Billion	3.04 Billion	2.17 Billion	1.27 Billion	270 Million
Other Assets	-	-	-	-	2 Million	3 Million
Total Liabilities	8.68 Billion	11.3 Billion	11.3 Billion	8.16 Billion	8.07 Billion	7.51 Billion
Total Current Liabilities	6.27 Billion	7.19 Billion	7.19 Billion	5.93 Billion	5.8 Billion	5.39 Billion
Account Payables	1.13 Billion	1.65 Billion	1.65 Billion	1.09 Billion	1.1 Billion	1.09 Billion
Tax Payables	167 Million	113 Million	113 Million	126 Million	153 Million	19 Million
Short Term Debt	300 Million	335 Million	335 Million	335 Million	337 Million	337 Million
Deferred Revenue	167 Million	520 Million	520 Million	126 Million	2.97 Billion	2.56 Billion
Other Current Liabilities	4.67 Billion	4.69 Billion	4.69 Billion	4.37 Billion	1.39 Billion	1.4 Billion
Total Non Current Liabilities	2.4 Billion	4.11 Billion	4.11 Billion	2.23 Billion	2.26 Billion	2.11 Billion
Long-Term Debt	56 Million	61 Million	61 Million	59 Million	64 Million	57 Million
Deferred Revenue Non Current	-2.2 Billion	-	-	-	37 Million	36 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	2.35 Billion	143 Million	143 Million	143 Million	109 Million	110 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	74.73 Billion	72.28 Billion	72.28 Billion	71.71 Billion	71.54 Billion	69.55 Billion
Stock Holders Equity	74.73 Billion	72.28 Billion	72.28 Billion	71.71 Billion	71.54 Billion	69.55 Billion
Common Stock	3.84 Billion	3.84 Billion	3.84 Billion	3.84 Billion	3.84 Billion	3.84 Billion
Retained Earnings	55.93 Billion	54.73 Billion	54.73 Billion	55.25 Billion	55.36 Billion	55.15 Billion
Accumulated other comprehensive income	11.91 Billion	10.66 Billion	10.66 Billion	9.58 Billion	9.29 Billion	7.53 Billion
Common Stock Equity	74.73 Billion	72.28 Billion	72.28 Billion	71.71 Billion	71.54 Billion	69.55 Billion
Capital Lease Obligation	91 Million	61 Million	61 Million	59 Million	101 Million	94 Million
Total Investments	27.02 Billion	21.88 Billion	21.88 Billion	23.1 Billion	17.09 Billion	15.24 Billion
Total Debt	300 Million	396 Million	396 Million	394 Million	401 Million	394 Million
Net Debt	-16.54 Billion	-18.3 Billion	-18.3 Billion	-16.14 Billion	-17.64 Billion	-19.86 Billion

Balance Sheet Charts

NEPON Inc.

7985

Full Analysis

Annual Balance Sheets
Inner Mongolia Furui Medical Science Co., Ltd.

300049

Full Analysis

Annual Balance Sheets
Calix, Inc.

CALX

Full Analysis

Annual Balance Sheets
Kokopelli Inc.

4167

Full Analysis

Annual Balance Sheets
Corcept Therapeutics Incorporated

CORT

Full Analysis

Annual Balance Sheets
Urbanet Corporation Co.,Ltd.

3242

Full Analysis

Annual Balance Sheets

Global Stocks Search

Seikagaku Corporation (4548.T)

Annual Balance Sheets

Balance Sheet Charts

NEPON Inc.

Inner Mongolia Furui Medical Science Co., Ltd.

Calix, Inc.

Kokopelli Inc.

Corcept Therapeutics Incorporated

Urbanet Corporation Co.,Ltd.